Alvotech and STADA add to strategic alliance through denosumab partnership - STADA assumes marketing license for Alvotech’s proposed biosimilar referencing Prolia®/Xgeva® (denosumab) in Europe, including Switzerland and the UK, as well as rights in selected markets in Central Asia and the Middle ...
STADA and Alvotech secure approval for Uzpruvo, Europe’s first ustekinumab biosimilar to Stelara - Marketing authorization issued in European Economic Area for Uzpruvo®, the first biosimilar to Stelara®, a biologic therapy within ...
EMA Confirms Acceptance of Application for AVT04, a Proposed Biosimilar to Stelara® (ustekinumab) - Partners Alvotech and STADA have marketing authorization application (MAA) for ustekinumab accepted for filing by the European Medicines Agency (EMA) ...
Alvotech and STADA Broaden Access to Adalimumab Biosimilar in Europe - Launches in Belgium, Bulgaria, Croatia, Czech Republic, Latvia, Romania, and Slovenia, increasing availability of high-concentration, citrate-free adalimumab in Europe - Follows initial introduction of adalimumab in ninecountries: ...
Chrono24 presents global study on the booming market with luxury watches Prices, availability, demand and surprising desire to buy among millenials and Gen Z Karlsruhe/Germany, October 11, 2022 – With a comprehensive market study, Chrono24 shows how the market with luxury watches looks like worldwide. ...
Dear all, Please find attached the press release of Brenntag on the acquisition of the Thai finished lubes distributor Oils ‘R Us. For further information please see the press release below. If you have any questions, please do not hesitate to contact us. Best ...
